tradingkey.logo

Haleon PLC

HLN
10.980USD
+0.115+1.06%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
98.65BMarktkapitalisierung
44.86KGV TTM

Haleon PLC

10.980
+0.115+1.06%

mehr Informationen über Haleon PLC Unternehmen

Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.

Haleon PLC Informationen

BörsenkürzelHLN
Name des UnternehmensHaleon PLC
IPO-datumJul 18, 2022
CEOMcnamara (Brian)
Anzahl der mitarbeiter- -
WertpapierartDepository Receipt
GeschäftsjahresendeJul 18
AddresseBuilding 5, First Floor
StadtWEYBRIDGE
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited Kingdom
PostleitzahlKT13 0NY
Telefon441932822000
Websitehttps://www.haleon.com/
BörsenkürzelHLN
IPO-datumJul 18, 2022
CEOMcnamara (Brian)

Führungskräfte von Haleon PLC

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+154370.00%
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Ms. Marie-Anne Aymerich
Ms. Marie-Anne Aymerich
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Manvinder Singh S. Banga ,
Mr. Manvinder Singh S. Banga ,
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dame Vivienne Cox
Dame Vivienne Cox
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Asmita Dubey
Ms. Asmita Dubey
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Amanda J. Mellor
Ms. Amanda J. Mellor
Company Secretary
Company Secretary
--
--
Mr. Keith Choy
Mr. Keith Choy
President, Asia Pacific
President, Asia Pacific
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+154370.00%
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Ms. Marie-Anne Aymerich
Ms. Marie-Anne Aymerich
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Manvinder Singh S. Banga ,
Mr. Manvinder Singh S. Banga ,
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Oral health
848.00M
32.28%
Pain relief
625.00M
23.79%
Respiratory health
428.00M
16.29%
Vitamins, minerals and supplements
417.00M
15.87%
Therapeutic Skin Health and Other
249.00M
9.48%
Digestive health and other
60.00M
2.28%
Nach RegionUSD
Name
Umsatz
Anteil
EMEA and LatAm
1.12B
42.67%
Northern America
871.00M
33.16%
APAC
635.00M
24.17%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Oral health
848.00M
32.28%
Pain relief
625.00M
23.79%
Respiratory health
428.00M
16.29%
Vitamins, minerals and supplements
417.00M
15.87%
Therapeutic Skin Health and Other
249.00M
9.48%
Digestive health and other
60.00M
2.28%

Aktionärsstatistik

Aktualisiert: Sat, Nov 15
Aktualisiert: Sat, Nov 15
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Dodge & Cox
3.47%
Fidelity Management & Research Company LLC
2.00%
ClearBridge Investments, LLC
0.75%
Harding Loevner LP
0.40%
Wellington Management Company, LLP
0.35%
Andere
93.03%
Aktionäre
Aktionäre
Anteil
Dodge & Cox
3.47%
Fidelity Management & Research Company LLC
2.00%
ClearBridge Investments, LLC
0.75%
Harding Loevner LP
0.40%
Wellington Management Company, LLP
0.35%
Andere
93.03%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
5.64%
Investment Advisor
5.10%
Research Firm
0.76%
Hedge Fund
0.59%
Bank and Trust
0.18%
Family Office
0.07%
Family Office
0.06%
Family Office
0.06%
Individual Investor
0.01%
Andere
87.54%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
1065
546.76M
12.27%
-32.53M
2025Q3
1049
570.14M
12.80%
-16.29M
2025Q2
1049
577.49M
12.86%
-190.91M
2025Q1
1077
574.94M
12.79%
-194.57M
2024Q4
1094
745.67M
16.47%
-9.34M
2024Q3
1096
717.29M
15.74%
-81.04M
2024Q2
1078
719.27M
15.75%
-155.43M
2024Q1
1041
707.36M
15.49%
-53.58M
2023Q4
993
691.96M
14.98%
-58.05M
2023Q3
933
688.70M
14.92%
-37.88M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Dodge & Cox
154.38M
3.47%
-1.09M
-0.70%
Sep 30, 2025
Fidelity Management & Research Company LLC
89.11M
2%
-8.41M
-8.62%
Sep 30, 2025
ClearBridge Investments, LLC
33.35M
0.75%
+1.90M
+6.05%
Sep 30, 2025
Harding Loevner LP
17.91M
0.4%
-4.64M
-20.58%
Sep 30, 2025
Wellington Management Company, LLP
15.68M
0.35%
+2.47M
+18.70%
Sep 30, 2025
Fidelity Institutional Asset Management
14.89M
0.33%
+651.50K
+4.58%
Sep 30, 2025
Sculptor Capital Management, Inc
9.95M
0.22%
--
--
Sep 30, 2025
Managed Account Advisors LLC
9.04M
0.2%
-1.94M
-17.67%
Sep 30, 2025
Aristotle Capital Management, LLC
8.06M
0.18%
-134.23K
-1.64%
Sep 30, 2025
Altshuler Shaham Ltd.
7.94M
0.18%
--
--
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
VanEck Pharmaceutical ETF
6.34%
Franklin ClearBridge Enhanced Income ETF
1.87%
One Global ETF
0.65%
ActivePassive International Equity ETF
0.33%
SP Funds S&P World (ex-US) ETF
0.27%
Avantis Responsible International Equity ETF
0.13%
Avantis International Equity ETF
0.08%
Avantis International Large Cap Value ETF
0%
Unusual Whales Subversive Democratic Trading ETF
0%
Fidelity Blue Chip Value ETF
0%
Mehr Anzeigen
VanEck Pharmaceutical ETF
Anteil6.34%
Franklin ClearBridge Enhanced Income ETF
Anteil1.87%
One Global ETF
Anteil0.65%
ActivePassive International Equity ETF
Anteil0.33%
SP Funds S&P World (ex-US) ETF
Anteil0.27%
Avantis Responsible International Equity ETF
Anteil0.13%
Avantis International Equity ETF
Anteil0.08%
Avantis International Large Cap Value ETF
Anteil0%
Unusual Whales Subversive Democratic Trading ETF
Anteil0%
Fidelity Blue Chip Value ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 570.00M USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Aug 01, 2024
HLN.NB Final Cash Dividend of gross USD 0.051416 paid on Sep 19, 2024 going ex on Aug 16, 2024
Aug 16, 2024
Sep 19, 2024
Aug 16, 2024
Feb 29, 2024
HLN.NB Interim Cash Dividend of gross USD 0.105268 paid on May 16, 2024 going ex on Mar 14, 2024
Mar 15, 2024
May 16, 2024
Mar 14, 2024
Aug 02, 2023
HLN.NB Interim Cash Dividend of gross USD 0.043871 paid on Oct 05, 2023 going ex on Aug 24, 2023
Aug 25, 2023
Oct 05, 2023
Aug 24, 2023
Mar 02, 2023
HLN.NB Final Cash Dividend of gross USD 0.059732 paid on Apr 27, 2023 going ex on Mar 16, 2023
Mar 17, 2023
Apr 27, 2023
Mar 16, 2023

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI